J A Kemp will be offering a webinar entitled "Update on Plausibility" on February 22, 2022 from 4:00 pm to 5:00 pm (GMT). Ravi Srinivasan and Guy Brain of J A Kemp will cover recent developments in the assessment of whether a "plausible" disclosure of efficacy is present in the application as filed, including a discussion of the decision T 116/18 which has for the first time referred the topic of plausibility to the Enlarged Board of Appeal of the European Patent Office (pending as G 2/21). The Court of Appeal decision in Fibrogen v Akebia will also be covered, which discusses the issue of plausibility in the context of claims directed to the medical use of a functionally-defined active agent. The webinar will address the following topics:
• Plausibility at the EPO and in the English courts
• The referral of plausibility to the enlarged board of appeal of the EPO
• Functional features and plausibility
• The Court of Appeal case in Fibrogen v Akebia
• Plausibility considerations for patent applications
There is no registration fee for this webinar. However, those interested in registering for the webinar, should do so here.
Comments